HitGen
高管
查看带有其 16 名主要高管的组织结构图
HitGen 搜索最多的简介
- Jin Li, Chairman and Chief Executive Officer
- Barry Morgan, Chief Scientific Officer
- Brian Moloney, Chief Business Officer
创建提醒
跟踪 HitGen 的高管变动
生物技术
HitGen 拥有 2,327 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- Alentis Therapeutics 刚刚宣布为 181 筹款数百万美元。 (公布2024十一月20号).
- Metsera 刚刚宣布为 500 筹款数百万美元。 (公布2024十一月20号).
- TRexBio 刚刚宣布为 84 筹款数百万美元。 (公布2024十一月14号).
生物技术 行业的其他推荐联系人
消息
HitGen 的最新新闻稿
- Infographic | HitGen FY2024 Q3 Report
- Pharma Peers Unite to Build DNA-Encoded Libraries
- Infographic | HitGen FY2024H1 Report
- Bridge Biotherapeutics and HitGen Initiate Research Collaboration to Advance Novel Cancer Therapeutics Program
- Infographic | HitGen FY2023&2024Q1 Report
- Vernalis announces a drug discovery collaboration with C4X Discovery in inflammatory disease
- News Press
- HitGen Partners with LabCentral / BioLabs / MBC BioLabs to Accelerate Biotechnology Discovery
- Hox Therapeutics and Vernalis announce a drug discovery collaboration in oncology
- Get ready for the end-of-year sale! Discover the future of drug discovery with OpenDEL™ and save 20% off!
- View more press releases Close
通过电子邮件
